index

Low Libido During Menopause: What’s Really Happening

For many women, low libido initially feels like one more menopause symptom they are expected to quietly accept.

Hot flashes? Expected. Bad sleep? Apparently inevitable. Brain fog? Add it to the list. And somewhere along the way, women are often given the impression that they should also stop caring about sex.

What can feel most unsettling is not simply wanting sex less often. It is the sense of becoming disconnected from a part of oneself that used to feel natural.

A woman can still love her partner. She can still want closeness. She may even think sex sounds like a good idea—in theory.

But her body may not be joining the conversation.

That difference is hard to explain until it happens. Attraction may still be there. What has changed is the easy access to desire.

Despite what women are often told, that does not come down to one hormone.

Desire is influenced by hormones, the nervous system, physical comfort, sleep, emotional health, medications, body image, stress, relationship dynamics—and whether a woman has had a single uninterrupted thought all day.

Once all of that is considered, low libido stops looking like a personal failure. It starts looking like a reasonable response to everything the body and brain are trying to manage.

Libido Is Not an On-Off Switch

Sex drive is often discussed as though it is a fixed amount of fuel stored somewhere in the body.

A woman either has it or she does not. High or low. Working or broken.

That is not how desire works for many women, particularly during perimenopause and menopause.

Desire is often an outcome. It appears when enough other things are going well: sex does not hurt, the nervous system is not on high alert, sleep has been reasonably restorative, and the body feels comfortable

When those conditions disappear, desire often goes with them.

There is also no correct amount of sex a woman is supposed to want. Low desire becomes a concern when the change bothers her, causes distress or creates difficulty in her life or relationship. It is not automatically a disorder simply because her level of interest does not match someone else’s expectations.

That distinction matters.

What Is Actually Changing in the Body?

Estrogen is fluctuating—and the tissues notice

One of the more misleading things women hear about perimenopause is that estrogen simply declines.

It would almost be easier if it did.

During perimenopause, estrogen can rise, fall and behave unpredictably before eventually settling at lower levels after menopause. These fluctuations can affect sleep, temperature regulation, mood and sexual function.

Estrogen also helps maintain the moisture, blood flow, elasticity and thickness of the tissues around the vagina, vulva and urinary tract. As estrogen decreases, those tissues can become drier, thinner, less flexible and more easily irritated.

This is called genitourinary syndrome of menopause, or GSM. The name is spectacularly unsexy, but the symptoms are very real:

  • Vaginal or vulvar dryness
  • Burning, itching or irritation
  • Pain during penetration
  • Reduced lubrication
  • Longer arousal time
  • Bleeding or soreness after sex
  • Urinary urgency or recurring urinary discomfort

These changes can begin during perimenopause, although some women do not notice them until several years after their final period.

Here is the part that should be obvious but is often ignored:

When sex starts to hurt, a woman stops wanting it.

That is not her libido malfunctioning. It is her brain learning from experience.

If penetration hurt the last three times, her body is unlikely to approach the fourth time with joyful anticipation. She may tense up before anything even happens. That tension makes arousal and lubrication more difficult, which can make sex hurt even more.

A physical problem becomes an emotional one. Then it gets labeled “low desire.”

Testosterone matters—but it is not the master switch

Women produce testosterone, and it does play a role in sexual motivation and response.

But menopause does not create a simple equation in which testosterone drops and libido disappears. Blood testosterone levels do not reliably explain sexual desire in individual women. Pain, distress, stress and relationship conflict may be more strongly associated with low desire than a particular hormone measurement.

That does not mean testosterone therapy is never useful.

Clinical guidelines support considering systemic testosterone for appropriately diagnosed postmenopausal women with hypoactive sexual desire disorder, or HSDD, after other contributors have been evaluated. HSDD involves persistently low desire that causes meaningful personal distress and is not better explained by another condition, medication or relationship issue.

The key phrase is after other contributors have been evaluated.

Testosterone should not be treated as the universal answer every time a woman says she feels tired, disconnected or uninterested in sex. A laboratory value cannot tell a doctor whether intercourse hurts, whether she is sleeping four hours a night or whether she is furious that her partner considers loading the dishwasher a personal favor.

Hormones matter. Context does too.

The nervous system matters too

Sexual desire does not begin in the ovaries. It begins in a brain deciding whether this is a good time to be open, curious and responsive.

That is difficult when the nervous system believes the body is under threat.

The threat does not have to be dramatic. It can be a deadline, an aging parent, financial uncertainty, a child who needs help, a body that suddenly feels unfamiliar or the constant low-level pressure of being responsible for everyone else.

Chronic stress keeps part of the brain scanning for the next problem. A woman may be physically present with her partner while mentally reorganizing tomorrow’s schedule.

Research supports what many women already know from experience: stress dysregulation, depression and sleep problems are associated with poorer desire, arousal, satisfaction and overall sexual health.

It is hard to feel desire while the body is bracing.

Poor sleep takes more than energy

Many women reach a point during menopause when they feel as though they have lost interest in everything.

Often, they are exhausted.

Night sweats, insomnia and middle-of-the-night waking can leave a woman functioning in a strange half-life. She can do her job, answer questions, make appointments and appear perfectly competent. But there is very little left over for pleasure.

Sleep disruption associated with menopause can reduce sexual interest, while fatigue and mood changes can compound the problem.

Sometimes the first step toward feeling sexual again is not lingerie, a date night or a weekend away.

It is getting serious about why she is awake at 3:00 a.m.

The Misconceptions That Make Everything Worse

“Women should want sex before it starts.”

Many women experience what is known as responsive desire.

That means desire does not always arrive first. A woman may begin with openness rather than hunger. Interest develops after affectionate touch, conversation, stimulation or a sense of emotional connection.

This can feel confusing when she is waiting for the spontaneous desire she remembers from an earlier stage of life.

She may keep thinking, “I shouldn’t start anything unless I already want it.”

A better question is:

Is she open to seeing whether desire develops?

That is not the same as forcing herself to participate. Consent and comfort remain essential. But desire does not always need to appear before the first kiss. Sometimes it arrives after the brain has had time to leave the grocery list behind.

“It is all low testosterone.”

This is an appealing explanation because it is simple.

Take a test. Find a low number. Replace the missing hormone. Problem solved.

Real bodies are less cooperative.

Low desire can involve hormonal changes, painful sex, medications, depression, anxiety, exhaustion, body image, relationship conflict or years of sex that has simply not been very pleasurable.

Testosterone may be part of the discussion. It should not prevent the rest of the discussion from happening.

“Pain is a normal part of getting older.”

Pain may be common. It is not something women are required to tolerate.

Vaginal dryness and GSM are treatable. Depending on a woman’s symptoms and medical history, options may include lubricants, vaginal moisturizers, low-dose vaginal estrogen, vaginal DHEA, prescription ospemifene or pelvic floor physical therapy.

The most useful lesson is simple:

Treat pain before trying to fix desire.

No supplement, romantic weekend or communication exercise can make painful sex genuinely appealing.

What Actually Helps

Start with physical comfort

The first question should not be how to increase libido.

It should be whether anything hurts.

A lubricant is used during sexual activity to reduce friction. A vaginal moisturizer is different; it is used consistently to help manage ongoing dryness, whether or not a woman is having sex.

It may take some trial and error to find products that feel comfortable. “Water-based” or “natural” does not automatically mean a product will work well for every body.

When over-the-counter products are not enough, a menopause-informed clinician can help. Vaginal estrogen and other prescription options can be remarkably effective for the right person, and improvement may occur within weeks.

Address the mental load honestly

Stress reduction is often presented to women as another job: meditate, journal, exercise, practice gratitude and somehow become less overwhelmed without changing anything that is overwhelming them.

Sometimes a woman does not need a better coping technique. She needs someone else to take responsibility for something.

Consider what happens before intimacy. Is she still answering questions, cleaning up and managing household responsibilities for tomorrow?

Desire needs mental space. Creating that space may require a more honest conversation about labor, resentment and who gets to rest.

Protect sleep as though it affects everything—because it does

Night sweats deserve treatment. Possible sleep apnea should be investigated. Alcohol use, anxiety, restless legs and habits that make it difficult to return to sleep should all be considered.

Poor sleep should not be dismissed as simply another menopause inconvenience.

Sleep affects mood, patience, energy, appetite, concentration and sexual responsiveness. It is hard for a woman to feel like herself when her brain has not been properly restored in months.

Review medications without stopping them abruptly

Some antidepressants and other medications can affect desire, arousal or orgasm.

That does not mean a woman should stop taking a medication that is helping her. It means sexual side effects deserve to be part of the conversation with her healthcare provider.

Sometimes a dose adjustment, timing change or alternative medication may be appropriate. Sometimes the medication is not the main issue. The point is to investigate rather than assume.

Move in ways that reconnect the body and mind

Exercise can support sleep, mood, circulation, energy and confidence. Movement can help a woman experience her body as a place she inhabits rather than a list of symptoms she is managing.

Where Chaly Fits

Chaly is not an instant aphrodisiac. It is not hormone therapy, and it is not a treatment for painful sex or a diagnosed sexual disorder.

Chaly can help supportsome of the conditions that make desire easier to access: better stress resilience, steadier mood, improved sleep and a greater sense of emotional balance.

Chaly contains 600 mg of KSM-66® Ashwagandha and 28 mg of Affron® saffron extract.

In an eight-week randomized, placebo-controlled study, healthy women who took 600 mg per day of ashwagandha root extract reported greater improvements in measures of sexual desire, arousal, lubrication, orgasm, satisfaction and distress than women taking a placebo.

The participants were between 18 and 50 and did not have hormonal disturbances, so the findings should not be presented as proof that ashwagandha treats menopausal low libido. They do, however, offer useful evidence that stress support and sexual wellbeing may be connected.

Affron has been studied at 28 mg per day for its effects on mood, perceived stress and anxiety-related symptoms. It has also been studied specifically in perimenopausal women, with improvements reported in mood and psychological symptoms compared with placebo.

That is the most realistic way to understand Chaly’s role.

It does not create desire on command. It helps support the foundation beneath it.

Sometimes that foundation needs several kinds of help. Chaly may be one piece alongside treating vaginal dryness, improving sleep, reviewing medications, reducing stress, and increasing exercise.

The Truth About Low Libido

Desire is sensitive.

It notices when a woman is exhausted.

It notices when sex hurts.

It notices when she does not feel at home in her body.

Low libido is not proof that a woman has stopped being sexual. It may be evidence that her body needs different conditions now.

More comfort. More time. More honesty. Less pressure.

She does not have to become the woman she was before menopause.

She gets to discover what feels good to the woman she is now.

She is not broken.

She is paying attention.

This article is for educational purposes only and is not a substitute for individualized medical advice. Speak with a qualified healthcare professional about persistent low desire, sexual pain, bleeding, vaginal or urinary symptoms, or sexual changes that are causing distress. Dietary supplements are not intended to diagnose, treat, cure or

Our Commitment to You

Quality & Transparency

At Chaly, transparency is more than a promise — it’s our process. From responsibly sourced ingredients to certified U.S. manufacturing and protective, recyclable packaging, every step is carefully controlled, documented, and verified. Our products are made in facilities that meet strict quality and safety standards, with full ingredient traceability and rigorous testing to ensure purity, consistency, and integrity in every batch.

At Chaly, transparency isn’t a marketing phrase — it’s a promise. Every product we create is manufactured in the United States in facilities that meet and exceed the highest safety and quality standards in the supplement industry.

Our manufacturing partner operates under current Good Manufacturing Practices (cGMP) for dietary supplements, ensuring strict control, consistency, and product integrity at every stage of production. Their advanced facilities include in-house analytical, quality assurance, and accredited microbiological laboratories, allowing for rigorous testing, verification, and safety monitoring throughout the manufacturing process.

This commitment to precision, safety, and accountability ensures that every product is produced with the care and standards your body deserves.

Our U.S.-based manufacturing facility maintain the following certifications:

- cGMP compliant to the Dietary Supplement Rule
- Certified Organic
- Kosher Certified
- Non-GMO Project Verified
- Fair for Life Certified
- SQF Level 2 Certified

At Chaly, transparency means knowing exactly what goes into your body — and where it comes from. Every ingredient in our formulas is fully traceable from raw source to finished product, ensuring purity, authenticity, and quality at every step.

Each batch of Chaly Vida Menopause Capsules is documented through a complete traceability system that tracks ingredient origin, supplier verification, and production records. This process ensures consistency, safety, and full accountability throughout manufacturing.

Key ingredients are sourced from trusted, quality-verified suppliers:

  • Organic Ashwagandha Root Extract (KSM-66®) — Ixoreal, USA
  • Maca Root Extract — AuNutra, USA
  • Fennel Seed Extract — AuNutra, USA
  • Saffron Stigma Extract (Affron®) — PharmActiv, Spain

Each ingredient undergoes identity, purity, and quality testing before production, and every finished batch is recorded and traceable for full transparency and safety assurance.

Chaly bottles are manufactured in the United States using high-quality, food-grade HDPE (High-Density Polyethylene)— a trusted material used in pharmaceutical and nutraceutical packaging for its strength, purity, and product protection.

Each container is produced under strict quality standards and inspected for structural integrity, cleanliness, and consistency to ensure your supplements remain safe, protected, and effective.

  • Material: Food-grade HDPE
  • Capacity: 225 cc
  • Neck Finish: 45-400 mm secure seal
  • Color: White, quality-verified
  • Made in: USA
  • Microbial Cleanliness Tested
  • Recyclable

Designed to protect product freshness while supporting responsible, sustainable packaging.

We have initiated Clean Label application. 

Clean Label Project™ is all about uncovering what product labels don’t tell you, so you can feel better about the things you use every day. Regular food safety checks often stop at bacteria and pathogens—but we dig deeper, looking for hidden stuff like heavy metals, pesticides, and plasticizers that most people never hear about.

Using real data and solid science, we’re raising the bar for product safety and recognizing brands that truly care about purity and transparency. If you want safer, cleaner products on the shelves, you choose for a Clean Label certified product. 

https://cleanlabelproject.org